Source:http://linkedlifedata.com/resource/pubmed/id/16123773
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2005-11-18
|
pubmed:abstractText |
A polymorphism of the dopamine transporter gene (DAT1, 10-repeat) is associated with attention-deficit hyperactivity disorder (ADHD) and has been linked to an enhanced response to methylphenidate (MPH). One aspect of the attention deficit in ADHD includes a subtle inattention to left space, resembling that seen after right cerebral hemisphere damage. Since left-sided inattention in ADHD may resolve when treated with MPH, we asked whether left-sided inattention in ADHD was related to DAT1 genotype and the therapeutic efficacy of MPH. A total of 43 ADHD children and their parents were genotyped for the DAT1 3' variable number of tandem repeats polymorphism. The children performed the Landmark Test, a well-validated measure yielding a spatial attentional asymmetry index (leftward to rightward attentional bias). Parents rated their child's response to MPH retrospectively using a three-point scale (no, mediocre or very good response). Additionally, parents used a symptom checklist to rate behavior while on and off medication. A within-family control design determined whether asymmetry indices predicted biased transmission of 10-repeat parental DAT1 alleles and/or response to MPH. It was found that left-sided inattention predicted transmission of the 10-repeat allele from parents to probands and was associated with the severity of ADHD symptomatology. Children rated as achieving a very good response to MPH displayed left-sided inattention, while those rated as achieving a poorer response did not. Our results suggest a subgroup of children with ADHD for whom the 10-repeat DAT1 allele is associated with left-sided inattention. MPH may be most efficacious in this group because it ameliorates a DAT1-mediated hypodopaminergic state.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Central Nervous System Stimulants,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Plasma Membrane Transport...,
http://linkedlifedata.com/resource/pubmed/chemical/Methylphenidate,
http://linkedlifedata.com/resource/pubmed/chemical/SLC6A3 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0893-133X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2290-7
|
pubmed:dateRevised |
2011-5-18
|
pubmed:meshHeading |
pubmed-meshheading:16123773-Adolescent,
pubmed-meshheading:16123773-Attention,
pubmed-meshheading:16123773-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:16123773-Central Nervous System Stimulants,
pubmed-meshheading:16123773-Child,
pubmed-meshheading:16123773-Dopamine,
pubmed-meshheading:16123773-Dopamine Plasma Membrane Transport Proteins,
pubmed-meshheading:16123773-Female,
pubmed-meshheading:16123773-Functional Laterality,
pubmed-meshheading:16123773-Genotype,
pubmed-meshheading:16123773-Humans,
pubmed-meshheading:16123773-Male,
pubmed-meshheading:16123773-Methylphenidate,
pubmed-meshheading:16123773-Psychiatric Status Rating Scales,
pubmed-meshheading:16123773-Retrospective Studies
|
pubmed:year |
2005
|
pubmed:articleTitle |
Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
|
pubmed:affiliation |
Department of Psychology and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland. bema@unimelb.edu.au
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|